Anhydrous Citric Acid, Dextrose Monohydrate, and Trisodium Citrate Dihydrate

FDA Drug Profile — Anticoagulant Citrate Dextrose A

Anhydrous Citric Acid, Dextrose Monohydrate, and Trisodium Citrate Dihydrate is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Anticoagulant Citrate Dextrose A. Available dosage form: solution.

Drug Details

Generic Name
Anhydrous Citric Acid, Dextrose Monohydrate, and Trisodium Citrate Dihydrate
Brand Names
Anticoagulant Citrate Dextrose A
Application Number
BN020037
Sponsor
Citra Labs LLC
NDC Codes
1
Dosage Forms
SOLUTION
Routes
EXTRACORPOREAL
Active Ingredients
DEXTROSE MONOHYDRATE, ANHYDROUS CITRIC ACID, TRISODIUM CITRATE DIHYDRATE

Indications and Usage

Indications and Usage Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P. (ACD-A), is intended for use as an anticoagulant in the extracorporeal blood processing with Autologous PRP Systems in production of platelet rich plasma (PRP). Refer to the manufacturer's Operator's Manual of the Autologous PRP System for the Directions for Use.

Warnings

Warnings NOT FOR DIRECT INTRAVENOUS INFUSION